Lingbin Meng

3.9k total citations · 3 hit papers
74 papers, 2.8k citations indexed

About

Lingbin Meng is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Lingbin Meng has authored 74 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 22 papers in Pulmonary and Respiratory Medicine and 14 papers in Oncology. Recurrent topics in Lingbin Meng's work include Head and Neck Cancer Studies (12 papers), Lung Cancer Treatments and Mutations (9 papers) and Effects of Radiation Exposure (8 papers). Lingbin Meng is often cited by papers focused on Head and Neck Cancer Studies (12 papers), Lung Cancer Treatments and Mutations (9 papers) and Effects of Radiation Exposure (8 papers). Lingbin Meng collaborates with scholars based in United States, China and Taiwan. Lingbin Meng's co-authors include Xin Jiang, Ying Xin, Jinlong Wei, Qihe Zhang, Bin Wang, Ge Yang, Pinyi Liu, Qin Zhao, Zhuangzhuang Zheng and Huanhuan Wang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Lingbin Meng

69 papers receiving 2.7k citations

Hit Papers

The role of short-chain fatty acids in intestinal barrier... 2021 2026 2022 2024 2021 2021 2021 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The role of short-chain fatty acids in intestinal barrier function, inflammation, oxidative stress, and colonic carcinogenesis
    2021 491 citations Pinyi Liu, Ge Yang et al. profile →
  2. Role of the gut microbiota in type 2 diabetes and related diseases
    2021 284 citations Ge Yang, Jinlong Wei et al. Metabolism profile →
  3. Targeting hypoxia in the tumor microenvironment: a potential strategy to improve cancer immunotherapy
    2021 215 citations Bin Wang, Qin Zhao et al. Journal of Experimental & Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingbin Meng United States 26 1.3k 462 427 378 364 74 2.8k
Mingyuan Wu China 30 977 0.8× 199 0.4× 442 1.0× 220 0.6× 387 1.1× 107 3.8k
Changli Wang China 29 935 0.7× 717 1.6× 953 2.2× 156 0.4× 143 0.4× 143 2.6k
Sandeep Kumar United States 38 2.1k 1.7× 537 1.2× 318 0.7× 83 0.2× 333 0.9× 129 4.1k
Marián Adamkov Slovakia 24 631 0.5× 308 0.7× 212 0.5× 90 0.2× 199 0.5× 115 1.8k
Pei‐Ling Hsieh Taiwan 31 1.1k 0.9× 194 0.4× 240 0.6× 45 0.1× 255 0.7× 109 2.4k
Jan Korbecki Poland 25 1.2k 1.0× 327 0.7× 790 1.9× 117 0.3× 278 0.8× 57 3.5k
Mei Liu China 32 2.0k 1.6× 192 0.4× 351 0.8× 33 0.1× 300 0.8× 108 3.2k
Javier Milara Spain 32 886 0.7× 1.7k 3.7× 307 0.7× 43 0.1× 770 2.1× 121 3.1k

Countries citing papers authored by Lingbin Meng

Since Specialization
Citations

This map shows the geographic impact of Lingbin Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingbin Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingbin Meng more than expected).

Fields of papers citing papers by Lingbin Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingbin Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingbin Meng. The network helps show where Lingbin Meng may publish in the future.

Co-authorship network of co-authors of Lingbin Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Lingbin Meng. A scholar is included among the top collaborators of Lingbin Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingbin Meng. Lingbin Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meng, Lingbin, et al.. (2025). CNPY2 drives DSS-induced colitis via the macrophage-ROS axis. Biomedicine & Pharmacotherapy. 187. 118078–118078.
2.
Kim, Doyeon, et al.. (2025). A novel TLR4 accessory molecule drives hepatic oncogenesis through tumor-associated macrophages. Cancer Letters. 614. 217543–217543. 2 indexed citations
3.
Sun, Fengjiao, Jiangong Wang, Lingbin Meng, et al.. (2024). AdipoRon promotes amyloid‐β clearance through enhancing autophagy via nuclear GAPDH‐induced sirtuin 1 activation in Alzheimer's disease. British Journal of Pharmacology. 181(17). 3039–3063. 8 indexed citations
4.
Wang, Bin, Yuyu Zhang, Qin Zhao, et al.. (2023). Overcoming acquired resistance to cancer immune checkpoint therapy: potential strategies based on molecular mechanisms. Cell & Bioscience. 13(1). 120–120. 48 indexed citations
5.
Liu, Zijing, Zhuangzhuang Zheng, Lihua Dong, et al.. (2022). Efficacy and safety of apatinib in patients with recurrent or metastatic head and neck squamous cell carcinoma: a retrospective multi-center study. Scientific Reports. 12(1). 18327–18327. 4 indexed citations
6.
Zheng, Zhuangzhuang, Zijing Liu, Haifeng Zhang, et al.. (2022). Efficacy and Safety of Apatinib in Advanced Hepatocellular Carcinoma: A Multicenter Real World Retrospective Study. Frontiers in Pharmacology. 13. 894016–894016. 12 indexed citations
7.
Zhang, Qihe, Huanhuan Wang, Qin Zhao, et al.. (2021). Evaluation of Risk Factors for Laryngeal Squamous Cell Carcinoma: A Single-Center Retrospective Study. Frontiers in Oncology. 11. 606010–606010. 15 indexed citations
8.
Zheng, Zhuangzhuang, Bin Wang, Qin Zhao, et al.. (2021). Research progress on mechanism and imaging of temporal lobe injury induced by radiotherapy for head and neck cancer. European Radiology. 32(1). 319–330. 17 indexed citations
9.
Yang, Ge, Jinlong Wei, Pinyi Liu, et al.. (2021). Role of the gut microbiota in type 2 diabetes and related diseases. Metabolism. 117. 154712–154712. 284 indexed citations breakdown →
10.
Wang, Shudong, Haiying Zhang, Ge Yang, et al.. (2021). Sulforaphane prevents angiotensin II‐induced cardiomyopathy by activation of Nrf2 through epigenetic modification. Journal of Cellular and Molecular Medicine. 25(9). 4408–4419. 28 indexed citations
11.
Wang, Bin, Qin Zhao, Yuyu Zhang, et al.. (2021). Targeting hypoxia in the tumor microenvironment: a potential strategy to improve cancer immunotherapy. Journal of Experimental & Clinical Cancer Research. 40(1). 24–24. 215 indexed citations breakdown →
12.
Dong, Xuesong, et al.. (2019). YAP/TAZ: a promising target for squamous cell carcinoma treatment. SHILAP Revista de lepidopterología. 2 indexed citations
13.
Dong, Xiaoming, Lingbin Meng, Pinyi Liu, et al.. (2019). <p>YAP/TAZ: a promising target for squamous cell carcinoma treatment</p>. Cancer Management and Research. Volume 11. 6245–6252. 15 indexed citations
14.
Meng, Lingbin, Rui Ji, Xiaoming Dong, et al.. (2019). Antitumor activity of ginsenoside Rg3 in melanoma through downregulation of the ERK and Akt pathways. International Journal of Oncology. 54(6). 2069–2079. 43 indexed citations
15.
16.
Wei, Jinlong, Lingbin Meng, Chao Qu, et al.. (2018). Radiation-induced skin reactions: mechanism and treatment. Cancer Management and Research. Volume 11. 167–177. 154 indexed citations
17.
Meng, Lingbin, et al.. (2018). Targeting the BDNF/TrkB pathway for the treatment of tumors (Review). Oncology Letters. 17(2). 2031–2039. 64 indexed citations
18.
Jiang, Xin, et al.. (2018). Transplantation of Bone Marrow Mesenchymal Stem Cells Prevents Radiation‐Induced Artery Injury by Suppressing Oxidative Stress and Inflammation. Oxidative Medicine and Cellular Longevity. 2018(1). 5942916–5942916. 29 indexed citations
19.
Ji, Rui, Lingbin Meng, Xin Jiang, et al.. (2014). TAM Receptors Support Neural Stem Cell Survival, Proliferation and Neuronal Differentiation. PLoS ONE. 9(12). e115140–e115140. 49 indexed citations
20.
Meng, Lingbin, Xin Jiang, & Rui Ji. (2014). Role of neurotrophin in the taste system following gustatory nerve injury. Metabolic Brain Disease. 30(3). 605–613. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mingyuan Wu Breakdown of academic impact, for papers by Changli Wang Breakdown of academic impact, for papers by Sandeep Kumar Breakdown of academic impact, for papers by Marián Adamkov Breakdown of academic impact, for papers by Pei‐Ling Hsieh Breakdown of academic impact, for papers by Jan Korbecki Breakdown of academic impact, for papers by Mei Liu Breakdown of academic impact, for papers by Javier Milara
Rankless by CCL
2026